Jennison Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $23.3M | Sell |
|
|||||
|
2022
Q4 | $59.6M | Sell |
|
|||||
|
2022
Q3 | $108M | Buy |
|
|||||
|
2022
Q2 | $105M | Sell |
|
|||||
|
2022
Q1 | $147M | Buy |
|
|||||
|
2021
Q4 | $146M | Buy |
|
|||||
|
2021
Q3 | $105M | Buy |
|
|||||
|
2021
Q2 | $88.5M | Buy |
|
|||||
|
2021
Q1 | $84.8M | Buy |
|
|||||
|
2020
Q4 | $62.1M | Buy |
|
|||||
|
2020
Q3 | $64.2M | Sell |
|
|||||
|
2020
Q2 | $62.7M | Sell |
|
|||||
|
2020
Q1 | $59.1M | Buy |
|
|||||
|
2019
Q4 | $70.9M | Sell |
|
|||||
|
2019
Q3 | $69.4M | Buy |
|
|||||
|
2019
Q2 | $57M | Buy |
|
|||||
|
2019
Q1 | $58.2M | Sell |
|
|||||
|
2018
Q4 | $43.4M | Buy |
|
|||||
|
2018
Q3 | $27.7M | Buy |
|